Alza, Knoll AG, Therapeutic Discovery Corp. deal

AZA exercised its option to license TDCA's Oros hydromorphone product for the once-daily

Read the full 133 word article

Trial Subscription

Get a two-week free trial subscription to BioCentury

SIGN UP

Article Purchase

This article may not be distributed to non-subscribers
More Info >PURCHASE